← Leaderboards
Jonathan C Trent
University Of Texas Md Anderson Can Ctr
$2,890,821
Attributed
$2,890,821
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.3K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,890,821 · 12
By mechanism
P30$2,148,080 · 6
K23$680,400 · 1
P41$62,341 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Scott M Lippman$54,535,308
- Richard E. Champlin$5,988,814
- Jheri J Dupart$105,021
- Lorenzo Cohen$18,186,221
- Marcos De Lima$1,407,443
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelSafetyClinical ResearchUniversitiesMonitorCancer Center Support GrantProtocols DocumentationEnsureMalignant NeoplasmsCatchment AreaComprehensive Cancer CenterResearch StudyUnited States National Institutes Of HealthServicesPeer ReviewRecruitMemberClinical TrialsAnticancer ResearchIndustryReportingDesignPoliciesMission
Grant awards (24)
Clinical Protocol and Data Management$372,003
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$88,262
P30 · FY2025 · CA · contact PI
Clinical Protocol and Data Management$343,531
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$74,793
P30 · FY2024 · CA · contact PI
Clinical Protocol and Data Management$228,655
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$40,472
P30 · FY2023 · CA · contact PI
Clinical Protocol and Data Management$221,996
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$39,291
P30 · FY2022 · CA · contact PI
Clinical Protocol and Data Management$215,528
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$38,146
P30 · FY2021 · CA · contact PI
Clinical Protocol and Data Management$209,254
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$37,035
P30 · FY2020 · CA · contact PI
Clinical Protocol and Data Management$203,157
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$35,957
P30 · FY2019 · CA · contact PI
CHAPERONIN (SULFOLOBUS SHIBATAE)$17,381
P41 · FY2009 · RR · contact PI
Activity & resistance of Gleevec in GI stromal tumors$136,080
K23 · FY2008 · CA · contact PI
CHAPERONIN (SULFOLOBUS SHIBATAE)$16,231
P41 · FY2008 · RR · contact PI
Activity & resistance of Gleevec in GI stromal tumors$136,080
K23 · FY2007 · CA · contact PI
CHAPERONIN (SULFOLOBUS SHIBATAE)$8,146
P41 · FY2007 · RR · contact PI
Mechanism/activity/resistance/Gleevec/GI stromal tumors (K23M)$136,080
K23 · FY2006 · CA · contact PI
CHAPERONIN (SULFOLOBUS SHIBATAE)$7,529
P41 · FY2006 · RR · contact PI
Mechanism/activity/resistance/Gleevec/GI stromal tumors (K23M)$136,080
K23 · FY2005 · CA
CHAPERONINS AS SELF-ASSEMBLING BUILDING BLOCKS FOR NANOTECHNOLOGY$13,054
P41 · FY2005 · RR
Activity &resistance of Gleevec in GI stromal tumors$136,080
K23 · FY2004 · CA